Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' DEFICIENCY (Details 1)

v2.4.0.6
STOCKHOLDERS' DEFICIENCY (Details 1) (USD $)
3 Months Ended 6 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
Mar. 31, 2012
Stock-based compensation expenses $ 338,000 $ 334,900 $ 693,500 $ 670,400
Cost Of Neurometric Services Revenues[Member]
       
Stock-based compensation expenses 2,700 2,600 5,200 5,100
Research [Member]
       
Stock-based compensation expenses 24,900 23,900 48,900 51,200
Product Development [Member]
       
Stock-based compensation expenses 30,000 17,700 49,000 34,600
Selling and Marketing Expense [Member]
       
Stock-based compensation expenses 44,700 49,100 99,100 97,900
General and Administrative Expense [Member]
       
Stock-based compensation expenses $ 235,700 $ 241,600 $ 491,300 $ 481,600